Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment ; day:18 ; month:1 ; year:2017 ; pages:1-9
European journal of clinical pharmacology ; (18.1.2017), 1-9
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Senek, Marina
- Contributor
-
Aquilonius, Sten-Magnus
Askmark, Hakan
Bergquist, Filip
Constantinescu, Radu
Ericsson, Anders
Lycke, Sara
Medvedev, Alexander
Memedi, Mevludin
Ohlsson, Fredrik
SPIRA, JACK
Westin, Jerker
Nyholm, Dag
SpringerLink (Online service)
- DOI
-
10.1007/s00228-017-2196-4
- URN
-
urn:nbn:de:1111-201702157577
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Senek, Marina
- Aquilonius, Sten-Magnus
- Askmark, Hakan
- Bergquist, Filip
- Constantinescu, Radu
- Ericsson, Anders
- Lycke, Sara
- Medvedev, Alexander
- Memedi, Mevludin
- Ohlsson, Fredrik
- SPIRA, JACK
- Westin, Jerker
- Nyholm, Dag
- SpringerLink (Online service)
Other Objects (12)
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease
Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs
Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
Motor fluctuations due to interaction between dietary protein and levodopa in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Disentangling nigral and putaminal contribution to motor impairment and levodopa response in Parkinson’s disease
Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease
Embelin and levodopa combination therapy for improved Parkinson’s disease treatment
Gut bacterial deamination of residual levodopa medication for Parkinson’s disease
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease